The government is considering giving central and prefectural governments more power over medical institutions in the event of a rapid spread of the coronavirus or other infectious diseases, several sources said.
It began discussions to revise the Infectious Diseases Control Law, hoping to submit a bill to an extraordinary Diet session scheduled for autumn.
Under proposals being considered, local governments would be authorized to take legally binding measures such as "ordering" medical institutions to secure hospital beds.
The second clause of Article 16 in the current law states that the health minister or a governor can request medical institutions to cooperate in the fight against infectious diseases. Under this provision, they are requesting hospitals to secure beds for COVID-19 patients.
Since a law revision in February last year, they are also allowed to "give a recommendation" -- stronger than a "request" -- to hospitals that fail, without justifiable grounds, to comply with their requests. Authorities can publicly announce the names of medical institutions that do not follow the recommendations, but a recommendation is still not a legal obligation.
During the fifth COVID-19 infection wave that lasted until last autumn, however, many hospital beds could not be used due to a shortage of medical staff. They were satirized as "ghost beds."
"Some medical institutions do not comply with requests, and there is a risk of a shortfall in hospital beds if the infections spread rapidly in the future," a senior health ministry official said.
Under the circumstances, the central government deemed it necessary to develop a legal framework in which local governments can take legally binding measures while taking account of frontline medical conditions, such as staff shortages.
The law revision has been low on the agenda since Prime Minister Fumio Kishida's administration was inaugurated in October last year, as it put priority on coping with the sixth wave of infections, driven by the omicron variant.
The central government wants legally binding instructions to be also issued in regard to the establishment and administration of temporary medical facilities, vaccinations and virus testing.
Meanwhile, when prefectures contain municipalities -- such as ordinance-designated cities, special wards and core cities -- that operate their own public health centers, a lack of coordination between the prefectural and municipal governments has been a problem. The central government is considering strengthening the powers of the governors of those prefectures to streamline the situation.
Opposition from medical associations and municipalities can be expected if the central and prefectural governments are given more authority, and the central government will carefully consider the requirements for issuing instructions.
5 million. doses of Novavax vaccine
The government has notified prefectures that 5 million doses of a COVID-19 vaccine developed by U.S. biopharmaceutical firm Novavax Inc. will be ready for nationwide distribution by July.
According to the Health, Labor and Welfare Ministry, 1 million doses are expected to be available from late May to mid-June, followed by 2 million doses in late June, and another 2 million doses in late July.
The Novavax vaccine is targeted at people 18 and older.
The ministry has asked prefectures to establish at least one vaccination site. Due to the increased vaccine supply, no limit has been set for the number of vaccination sites.
The Novavax vaccine, which is manufactured in Japan by Takeda Pharmaceutical Company, can be stored in an ordinary refrigerator at 2 C to 8 C, making it easy for medical institutions to store the product.
Read more from The Japan News at https://japannews.yomiuri.co.jp/
